Immunity Inflammation and Disease

Papers
(The H4-Index of Immunity Inflammation and Disease is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
The relationship between COVID‐19 viral load and disease severity: A systematic review82
Association between HLA gene polymorphisms and mortality of COVID‐19: An in silico analysis76
Does COVID‐19 contribute to development of neurological disease?56
Inflammation initiates a vicious cycle between obesity and nonalcoholic fatty liver disease53
Age‐related differences in the immune response could contribute to determine the spectrum of severity of COVID‐1945
The clinical outcomes of COVID‐19 in HIV‐positive patients: A systematic review of current evidence39
The effect of low serum calcium level on the severity and mortality of Covid patients: A systematic review and meta‐analysis38
Efficacy of canakinumab in mild or severe COVID‐19 pneumonia38
Role of neutrophils in acute viral infection38
Ferritin level: A predictor of severity and mortality in hospitalized COVID‐19 patients35
Impact of chronic endometritis on endometrial receptivity analysis results and pregnancy outcomes35
Current research status of HLA in immune‐related diseases31
The complex role of AIM2 in autoimmune diseases and cancers30
Adverse events following COVID‐19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia30
COVID‐19 associated EBV reactivation and effects of ganciclovir treatment29
Clinical efficacy of fecal microbial transplantation treatment in adults with moderate‐to‐severe atopic dermatitis27
The impact of COVID‐19 control measures on the morbidity of varicella, herpes zoster, rubella and measles in Guangzhou, China27
Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges26
Follow‐up of renal transplant recipients after acute COVID‐19—A prospective cohort single‐center study26
Pterostilbene suppresses oxidative stress and allergic airway inflammation through AMPK/Sirt1 and Nrf2/HO‐1 pathways26
A randomized controlled clinical trial on efficacy and safety of anakinra in patients with severe COVID‐1925
Polydatin has anti‐inflammatory and antioxidant effects in LPS‐induced macrophages and improves DSS‐induced mice colitis25
RNA m6A methylation regulates virus–host interaction and EBNA2 expression during Epstein–Barr virus infection25
Serum troponin, D‐dimer, and CRP level in severe coronavirus (COVID‐19) patients24
Tick salivary gland extract induces alpha‐gal syndrome in alpha‐gal deficient mice24
0.075375080108643